216 related articles for article (PubMed ID: 8811682)
1. Progressive supranuclear palsy: MRI and pathological findings.
Yagishita A; Oda M
Neuroradiology; 1996 May; 38 Suppl 1():S60-6. PubMed ID: 8811682
[TBL] [Abstract][Full Text] [Related]
2. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].
Yamamoto T; Oya Y; Ogawa M; Ogata K; Kawai M
Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364
[TBL] [Abstract][Full Text] [Related]
3. Relationship between brainstem MRI and pathological findings in progressive supranuclear palsy--study in autopsy cases.
Aiba I; Hashizume Y; Yoshida M; Okuda S; Murakami N; Ujihira N
J Neurol Sci; 1997 Nov; 152(2):210-7. PubMed ID: 9415543
[TBL] [Abstract][Full Text] [Related]
4. Study of the rostral midbrain atrophy in progressive supranuclear palsy.
Kato N; Arai K; Hattori T
J Neurol Sci; 2003 Jun; 210(1-2):57-60. PubMed ID: 12736089
[TBL] [Abstract][Full Text] [Related]
5. New and reliable MRI diagnosis for progressive supranuclear palsy.
Oba H; Yagishita A; Terada H; Barkovich AJ; Kutomi K; Yamauchi T; Furui S; Shimizu T; Uchigata M; Matsumura K; Sonoo M; Sakai M; Takada K; Harasawa A; Takeshita K; Kohtake H; Tanaka H; Suzuki S
Neurology; 2005 Jun; 64(12):2050-5. PubMed ID: 15985570
[TBL] [Abstract][Full Text] [Related]
6. MR vs CT in progressive supranuclear palsy.
Masucci EF; Borts FT; Perl SM; Wener L; Schwankhaus J; Kurtzke JF
Comput Med Imaging Graph; 1995; 19(4):361-8. PubMed ID: 8653674
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy.
Asato R; Akiguchi I; Masunaga S; Hashimoto N
J Neural Transm (Vienna); 2000; 107(12):1427-36. PubMed ID: 11458995
[TBL] [Abstract][Full Text] [Related]
8. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy.
Warmuth-Metz M; Naumann M; Csoti I; Solymosi L
Arch Neurol; 2001 Jul; 58(7):1076-9. PubMed ID: 11448296
[TBL] [Abstract][Full Text] [Related]
9. [Differentiation of atypical Parkinson syndrome and delineation from idiopathic Parkinson syndrome with routine magnetic resonance tomography].
Csoti I; Warmuth-Metz M; Solymosi L; Becker Dagger G; Fornadi F; Naumann M
Nervenarzt; 2004 Feb; 75(2):128-34. PubMed ID: 14770282
[TBL] [Abstract][Full Text] [Related]
10. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
[TBL] [Abstract][Full Text] [Related]
11. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
Eraslan C; Acarer A; Guneyli S; Akyuz E; Aydin E; Colakoglu Z; Kitis O; Calli MC
Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485
[TBL] [Abstract][Full Text] [Related]
12. Morning glory sign: a particular MR finding in progressive supranuclear palsy.
Adachi M; Kawanami T; Ohshima H; Sugai Y; Hosoya T
Magn Reson Med Sci; 2004 Dec; 3(3):125-32. PubMed ID: 16093629
[TBL] [Abstract][Full Text] [Related]
13. The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy.
Massey LA; Jäger HR; Paviour DC; O'Sullivan SS; Ling H; Williams DR; Kallis C; Holton J; Revesz T; Burn DJ; Yousry T; Lees AJ; Fox NC; Micallef C
Neurology; 2013 May; 80(20):1856-61. PubMed ID: 23616165
[TBL] [Abstract][Full Text] [Related]
14. Imaging-pathologic correlation in corticobasal degeneration.
Tokumaru AM; Saito Y; Murayama S; Kazutomi K; Sakiyama Y; Toyoda M; Yamakawa M; Terada H
AJNR Am J Neuroradiol; 2009 Nov; 30(10):1884-92. PubMed ID: 19833793
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy.
Hussl A; Mahlknecht P; Scherfler C; Esterhammer R; Schocke M; Poewe W; Seppi K
Mov Disord; 2010 Oct; 25(14):2444-9. PubMed ID: 20878992
[TBL] [Abstract][Full Text] [Related]
16. Cerebellar dentate nucleus in progressive supranuclear palsy.
Sawa N; Kataoka H; Kiriyama T; Izumi T; Taoka T; Kichikawa K; Ueno S
Clin Neurol Neurosurg; 2014 Mar; 118():32-6. PubMed ID: 24529226
[TBL] [Abstract][Full Text] [Related]
17. Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy.
Shiozawa M; Fukutani Y; Sasaki K; Isaki K; Hamano T; Hirayama M; Imamura K; Mukai M; Arai N; Cairns NJ
Clin Neuropathol; 2000; 19(4):192-9. PubMed ID: 10919351
[TBL] [Abstract][Full Text] [Related]
18. Midbrain-to-pons ratio in autopsy-confirmed progressive supranuclear palsy: replication in an independent cohort.
Kaasinen V; Kangassalo N; Gardberg M; Isotalo J; Karhu J; Parkkola R; Sonninen P
Neurol Sci; 2015 Jul; 36(7):1251-3. PubMed ID: 25805708
[TBL] [Abstract][Full Text] [Related]
19. Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease.
Azuma M; Hirai T; Nakaura T; Kitajima M; Yamashita S; Hashimoto M; Yamada K; Uetani H; Yamashita Y; Wang Y
J Neurol Sci; 2019 Nov; 406():116443. PubMed ID: 31634718
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.
Soliveri P; Monza D; Paridi D; Carella F; Genitrini S; Testa D; Girotti F
J Neurol Neurosurg Psychiatry; 2000 Sep; 69(3):313-8. PubMed ID: 10945805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
